Discovery of a potential therapeutic target to combat trypanosomes

October 26, 2017

Yaser Hashem's team at the Laboratoire Architecture et Réactivité de l'ARN at CNRS's has discovered a new potential therapeutic target - located in the ribosome - to combat trypanosomes parasites. Using cryo-electron microscopy[1], researchers at the Institut de Biologie Moléculaire et Cellulaire (CNRS/Université de Strasbourg) have analyzed the structure of these parasites in details and revealed one of their potential weak points, which has remained undetected until now. This discovery opens the path to the development of new safer therapies that are less toxic and more specific against trypanosomes, the parasites causing the Chagas disease and the African sleeping sickness. This study is published on October 26, 2017 in Structure.

Trypanosomes, more generally called kinetoplastids, are unicellular parasites responsible for numerous diseases of variable severity that can be lethal in the most severe cases. Trypanosoma brucei, Trypanosoma cruzi and Leishmania major are probably the best known and cause the African sleeping sickness, Chagas disease and various Leishmaniasis, respectively.

Unlike bacteria, these organisms are eukaryotic cells that contain a nucleus, just like human cells. The similarities, though low, between animal cells and trypanosome cells complicate some therapeutic approaches. For example, an antibiotic targeting given molecular machinery in trypanosomes such as the ribosome could harm human cells at the same time. Until now, researchers thought that eukaryotic ribosomes (molecules involved in protein synthesis) had extremely similar structures from one species of eukaryotes to another, such as for instance the case of humans and trypanosomes, making them almost untouchable. Recent technological advances made possible the visualization of the structure of the ribosomes from trypanosomes at near-atomic resolutions, thus small structural differences to the human ribosomes can now be seen and become a potential therapeutic target.

Yaser Hashem's team has particularly looked at the architecture of the Trypanosoma cruzi ribosome. Using cryo-electron microscopy - involving sample cryogenization, it allows biological structures to be visualized in their native state - in combination with mass spectrometry - using the mass of each element to determine a precise protein composition - they have brought to light a protein specific to the ribosome of trypanosomes: KSRP (kinetoplastid-specific ribosomal protein). In addition to being specific to these parasites, KSPR is essential to their survival since inhibiting its activity leads to death of the parasites. The exact role of KSRP in the protein synthesis remains unsolved.

This discovery of KSRP gives us a glimpse into possible future medical research for the development of new therapies against trypanosomes parasites. Elucidating the structure of this new protein could lead to designing molecules that can interact with and inhibit its activity in a highly specific way, without interfering with host cells. So the possibility of targeting and inhibiting KSRP in parasites will represent a safer alternative, and especially a more efficient alternative, compared to current treatments that are extremely difficult and toxic.
-end-
[1] Ribosome of the parasite Trypanosoma cruzi. Illustration of the cytosolic ribosome in trypanosomes, purified from the T. cruzi parasite. Structure analysis by cryo-electron microscopy (middle) of the ribosome shows a new protein that is specific to this family of organisms. This protein has been named Kinetoplastid-specific ribosomal protein, or KSRP. In spite of its constant presence, this protein has passed unnoticed for years, even after the first publication of the high-resolution structure of this ribosome. © Yaser Hashem.

CNRS

Related Parasites Articles from Brightsurf:

When malaria parasites trick liver cells to let themselves in
A new study led by Maria Manuel Mota, group leader at Instituto de Medicina Molecular, now shows that malaria parasites secrete the protein EXP2 that is required for their entry into hepatocytes.

How deadly parasites 'glide' into human cells
A group of scientists led by EMBL Hamburg's Christian Löw provide insights into the molecular structure of proteins involved in the gliding movements through which the parasites causing malaria and toxoplasmosis invade human cells.

How malaria parasites withstand a fever's heat
The parasites that cause 200 million cases of malaria each year can withstand feverish temperatures that make their human hosts miserable.

New studies show how to save parasites and why it's important
An international group of scientists published a paper, Aug. 1, 2020, in a special edition of the journal Biological Conservation that lays out an ambitious global conservation plan for parasites.

More flowers and pollinator diversity could help protect bees from parasites
Having more flowers and maintaining diverse bee communities could help reduce the spread of bee parasites, according to a new study.

How Toxoplasma parasites glide so swiftly (video)
If you're a cat owner, you might have heard of Toxoplasma gondii, a protozoan that sometimes infects humans through contact with contaminated feces in litterboxes.

Parasites and the microbiome
In a study of ethnically diverse people from Cameroon, the presence of a parasite infection was closely linked to the make-up of the gastrointestinal microbiome, according to a research team led by Penn scientists.

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Feeding bluebirds helps fend off parasites
If you feed the birds in your backyard, you may be doing more than just making sure they have a source of food: you may be helping baby birds give parasites the boot.

Scientists discover how malaria parasites import sugar
Researchers at Stockholm University has established how sugar is taken up by the malaria parasite, a discovery with the potential to improve the development of antimalarial drugs.

Read More: Parasites News and Parasites Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.